Absorption |
Blood-Brain Barrier | BBB+ | 0.5829 |
Human Intestinal Absorption | HIA+ | 0.9959 |
Caco-2 Permeability | Caco2+ | 0.9165 |
P-glycoprotein Substrate | Non-substrate | 0.7115 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9792 |
Non-inhibitor | 0.9866 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8890 |
Distribution |
Subcellular localization | Mitochondria | 0.8395 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7577 |
CYP450 2D6 Substrate | Non-substrate | 0.8555 |
CYP450 3A4 Substrate | Non-substrate | 0.7090 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.7361 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8619 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9791 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9055 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8508 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7961 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8554 |
Non-inhibitor | 0.9547 |
AMES Toxicity | Non AMES toxic | 0.9633 |
Carcinogens | Non-carcinogens | 0.7310 |
Fish Toxicity | Low FHMT | 0.5435 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.8518 |
Honey Bee Toxicity | High HBT | 0.7834 |
Biodegradation | Ready biodegradable | 0.6070 |
Acute Oral Toxicity | II | 0.5252 |
Carcinogenicity (Three-class) | Non-required | 0.5775 |